Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm’s mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.
https://ih.advfn.com/stock-market/NASDAQ/moderna-MRNA/stock-price

